Kindly MD, Inc. (KDLYW) Stock Analysis
DELISTED 2025
What happened to Kindly MD, Inc. (KDLYW) stock?
Kindly MD, Inc. (KDLYW) no longer trades on public markets. It was delisted in May 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kindly MD, Inc. (KDLYW) trades at $18.64. Kindly MD, Inc. provides direct healthcare services, integrating prescription medicine and behavioral health. They offer specialty outpatient clinical services on a subscription and fee-for-service basis. Market cap: $96.5M, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for KDLYW: KDLYW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KDLYW against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Kindly MD, Inc. (KDLYW) Healthcare & Pipeline Overview
Kindly MD, Inc. delivers integrated healthcare services, combining prescription medicine and behavioral health, primarily through subscription and fee-for-service models. The company focuses on specialty outpatient clinical services, operating within the evolving healthcare landscape and competing with established and emerging care providers.
What Is the Investment Thesis for KDLYW?
Kindly MD, Inc. presents a high-risk, high-reward investment opportunity within the evolving healthcare landscape. With a market capitalization of $96.5M and a negative P/E ratio of -0.02, the company's valuation is speculative. A gross margin of 98.8% suggests strong pricing power, but a profit margin of -4569.5% indicates significant operational challenges. Growth catalysts include expanding service offerings and scaling the subscription model. The company's beta of 2.50 indicates high volatility, reflecting the inherent risks in its early stage of development. Investors should closely monitor the company's ability to achieve profitability and manage its operational expenses.
Based on FMP financials and quantitative analysis
KDLYW Key Highlights
Market capitalization of $96.5M, reflecting its small-cap status and growth potential.
- P/E ratio of -0.02, indicating the company is currently unprofitable.
- Gross margin of 98.8%, showcasing a strong ability to control the direct costs associated with its services.
- Profit margin of -4569.5%, highlighting significant operational inefficiencies and high expenses relative to revenue.
- Beta of 2.50, indicating high volatility compared to the overall market.
Who Are KDLYW's Competitors?
KDLYW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AADI Aadi Bioscience, Inc. | $2.05 | -2.38% | $94.9M | 50 |
| ASXC Asensus Surgical, Inc. | $0.35 | +0.64% | $94.9M | 53 |
| FVE Five Star Senior Living Inc. | $2.94 | +2.44% | $98.4M | 39 |
| ICAD iCAD, Inc. | $3.87 | +3.75% | $106M | 54 |
| IMDX Insight Molecular Diagnostics Inc. | $4.38 | +2.34% | $141M | — |
| JYNT The Joint Corp. | $8.25 | +0.24% | $118M | 75 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
| HWAIF Healwell AI Inc. | $0.57 | +3.64% | $172M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KDLYW's Key Strengths?
Integrated care model combining prescription medicine and behavioral health.
- Subscription-based revenue model providing recurring income.
- Proprietary data collection and research capabilities.
- Strong gross margin of 98.8%.
What Are KDLYW's Weaknesses?
Negative profit margin of -4569.5% indicating operational inefficiencies.
- Limited brand recognition and market presence.
- High beta of 2.50 indicating high volatility.
- Small number of employees (23).
What Could Drive KDLYW Stock Higher?
Expansion of subscription services to new geographic markets within the next 12 months.
- Strategic partnerships with healthcare providers to expand referral network.
- Development and launch of proprietary healthcare data platform.
- Introduction of new healthcare products and services through online and retail channels within the next 6 months.
What Are the Key Risks for KDLYW?
Financial-distress signal — its Altman Z-Score of -3.35 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Competition from larger, more established healthcare providers with greater resources.
- Regulatory changes impacting the healthcare industry and reimbursement rates.
- Economic downturn affecting consumer spending on healthcare services.
- Data privacy and security breaches compromising patient information.
- The company's negative profit margin poses a risk to its long-term financial sustainability.
What Are the Growth Opportunities for KDLYW?
- Expansion of Subscription-Based Services: Kindly MD, Inc. can drive revenue growth by expanding its subscription-based service offerings. By offering tiered subscription packages with varying levels of access to services, the company can attract a wider range of customers and generate recurring revenue. A focus on customer retention and upselling within the subscription model will be crucial for long-term success. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, physician groups, and other healthcare providers can expand Kindly MD, Inc.'s reach and referral network. The healthcare partnership market is experiencing growth as providers seek to enhance their service offerings and improve patient outcomes. By integrating its services into existing healthcare systems, Kindly MD, Inc. can gain access to a larger patient base and establish credibility within the industry. Timeline: Ongoing.
- Geographic Expansion: Kindly MD, Inc. can pursue geographic expansion by opening new clinics or establishing telehealth services in underserved markets. The global telehealth market is projected to reach $55.6 billion by 2027. By targeting regions with limited access to specialized outpatient care, the company can capture new market share and address unmet patient needs. Careful market research and regulatory compliance will be essential for successful geographic expansion. Timeline: 1-3 years.
- Development of Proprietary Healthcare Data Platform: Leveraging its data collection and research capabilities, Kindly MD, Inc. can develop a proprietary healthcare data platform. The healthcare analytics market is projected to reach $34.4 billion by 2027. By offering data-driven insights and analytics to healthcare providers and researchers, the company can generate a new revenue stream and establish itself as a thought leader in the industry. Data privacy and security will be paramount in the development and operation of the platform. Timeline: 2-4 years.
- Enhancement of Online and Retail Presence: Kindly MD, Inc. can strengthen its online and retail presence by expanding its online store and opening new retail clinics. The global e-pharmacy market is projected to reach $177.8 billion by 2026. By offering a wider range of healthcare products and services through its online and retail channels, the company can increase brand awareness and drive sales. A focus on customer experience and convenience will be crucial for success in the competitive online and retail market. Timeline: Ongoing.
What Are KDLYW's Competitive Advantages?
- Integrated care model combining prescription medicine and behavioral health.
- Subscription-based revenue model providing recurring income.
- Proprietary data collection and research capabilities.
- Established presence in the Salt Lake City market.
What Does KDLYW Do?
Kindly MD, Inc., established in 2019 and based in Salt Lake City, Utah, operates as a healthcare and healthcare data company. Originally named Utah Therapeutic Health Center, LLC, the company rebranded to Kindly MD, Inc. in March 2022. Kindly MD, Inc. provides direct healthcare services to patients, integrating prescription medicine and behavioral health services. Their core offering revolves around specialty outpatient clinical services, available on both a subscription and fee-for-service basis, designed to complement traditional healthcare models. These services encompass a wide array of evaluation and management options, including chronic pain management, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel health, and hormone therapy. Beyond direct patient care, Kindly MD, Inc. engages in data collection and research activities. The company also provides online and email campaign marketing services and sells healthcare products through its clinics and online platform, creating multiple revenue streams.
What Products and Services Does KDLYW Offer?
- Provides direct healthcare services to patients.
- Integrates prescription medicine and behavioral health services.
- Offers specialty outpatient clinical services on a subscription and fee-for-service basis.
- Provides evaluation and management services for chronic pain, functional medicine, and mental health.
- Engages in data collection and research activities.
- Offers online and email campaign marketing services.
- Sells healthcare products through clinics and online.
How Does KDLYW Make Money?
- Subscription-based services for ongoing access to healthcare.
- Fee-for-service model for individual consultations and treatments.
- Retail sales of healthcare products through clinics and online.
- Data collection and research services for healthcare providers.
What Industry Does KDLYW Operate In?
Kindly MD, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized outpatient services and integrated care models. The competitive landscape includes established healthcare providers, specialized clinics, and emerging telehealth platforms. Kindly MD, Inc.'s focus on integrating prescription medicine and behavioral health positions it to capitalize on the growing trend towards holistic and patient-centric care. However, the company faces competition from larger, more established players with greater resources and brand recognition.
Who Are KDLYW's Key Customers?
- Individuals seeking specialized outpatient clinical services.
- Patients requiring integrated prescription medicine and behavioral health support.
- Healthcare providers seeking data-driven insights and research services.
- Consumers purchasing healthcare products online and in clinics.
Company Profile
Kindly MD, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Salt Lake City, US. The company is led by CEO Timothy Pickett. KDLYW has traded publicly since 2024.
Financial Health
Kindly MD, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.35 places it in the distress zone, a signal of elevated financial risk.
KDLYW Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Kindly MD's future prospects, signaling potential growth.
- Community sentiment indicates growing optimism about Kindly MD's strategic direction and market positioning.
- Bullish community views highlight the company's innovative approach to telemedicine and its potential impact on the healthcare sector.
- Market perception sees Kindly MD as a disrupter, potentially mirroring early enthusiasm for telehealth pioneers like Teladoc.
Bear Case
- Limited information and transparency raise concerns about Kindly MD's long-term viability and business model sustainability.
- Bearish community views question Kindly MD's ability to effectively compete with established players in the telemedicine space.
- Recent market developments suggest increased regulatory scrutiny of telehealth companies, potentially impacting Kindly MD's operations.
- Concerns exist regarding Kindly MD's marketing strategies and their effectiveness in attracting and retaining customers, similar to challenges faced by other early-stage telehealth firms.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
KDLYW Latest News
No recent news available for KDLYW.
Leadership: Timothy Pickett
CEO
Timothy Pickett serves as the CEO of Kindly MD, Inc., leading the company's strategic direction and overseeing its daily operations. His background includes experience in healthcare management and business development. He is responsible for managing a team of 23 employees and driving the company's growth initiatives. Prior to Kindly MD, Inc., Pickett held various leadership positions in the healthcare sector, focusing on improving patient care and expanding access to medical services. His expertise lies in integrating innovative technologies and service models to enhance the patient experience.
Track Record: Since assuming the role of CEO, Timothy Pickett has focused on expanding Kindly MD, Inc.'s service offerings and establishing strategic partnerships. Key achievements include the rebranding of the company from Utah Therapeutic Health Center to Kindly MD, Inc. and the development of the company's subscription-based service model. Under his leadership, Kindly MD, Inc. has also expanded its online and retail presence, increasing access to its healthcare products and services.
What Investors Ask About Kindly MD, Inc. (KDLYW) — Healthcare
What happened to Kindly MD, Inc. (KDLYW) stock?
Kindly MD, Inc. (KDLYW) no longer trades on public markets. It was delisted in May 2025. The figures below are historical and are not a current quote.
Can I still buy KDLYW shares?
No. KDLYW stopped trading on public markets in May 2025, so the shares are not available through a broker. Anything you see quoted for KDLYW elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KDLYW stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kindly MD, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Kindly MD, Inc. do?
Kindly MD, Inc. operates as an integrated healthcare provider, delivering direct patient care through a combination of prescription medicine and behavioral health services. The company offers specialized outpatient clinical services on a subscription and fee-for-service basis, augmenting traditional healthcare models.
What are the main risks for KDLYW?
Kindly MD, Inc. faces several key risks. Competition from larger, more established healthcare providers poses a significant threat. Regulatory changes in the healthcare industry could impact the company's operations and profitability. An economic downturn could reduce consumer spending on healthcare services. Data privacy and security breaches could damage the company's reputation and result in legal liabilities.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully representative of the company's current performance.
- AI analysis is pending and may provide additional insights.